buprenorphine and tianeptine

buprenorphine has been researched along with tianeptine* in 1 studies

Other Studies

1 other study(ies) available for buprenorphine and tianeptine

ArticleYear
Role of efficacy as a determinant of locomotor activation by mu-opioid receptor (MOR) ligands in female and male mice. II. Effects of novel MOR-selective phenylmorphans with high-to-low MOR efficacy.
    Pharmacology research & perspectives, 2023, Volume: 11, Issue:4

    Low-efficacy mu-opioid receptor (MOR) agonists represent promising therapeutics, but existing compounds (e.g., buprenorphine, nalbuphine) span a limited range of low MOR efficacies and have poor MOR selectivity. Accordingly, new and selective low-efficacy MOR agonists are of interest. A novel set of chiral C9-substituted phenylmorphans has been reported to display improved MOR selectivity and a range of high-to-low MOR efficacies under other conditions; however, a full opioid receptor binding profile for these drugs has not been described. Additionally, studies in mice will be useful for preclinical characterization of these novel compounds, but the pharmacology of these drugs in mice has also not been examined. Accordingly, the present study characterized the binding selectivity and in vitro efficacy of these compounds using assays of opioid receptor binding and ligand-stimulated [

    Topics: Analgesics, Opioid; Animals; Buprenorphine; Female; Guanosine 5'-O-(3-Thiotriphosphate); Ligands; Male; Mice; Receptors, Opioid, mu

2023